StockClub
ABUSArbutus Biopharma Corp$ --
Arbutus Biopharma Corp

Arbutus Biopharma Corp

ABUS

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

analyticsEarnings Summary

FY2025 Q3Updated: 09/30/2025

Revenue

attach_money
1M USD
-

Operating Income

trending_up
-8M USD
-

Net Income

verified
-8M USD
-

EPS

paid
-0.04$
-

Revenue

$529,000

BEAT
$1.6M
$1.8M
Q1
$1.6M
$10.7M
Q2
$1.3M
$529,000
Q3
$4.5M
$13M
Cumulative
Estimate (Forecast)Actual (Actual)
FY2025 Q3 YoY
- $-

Net Income

$-7.7M

BEAT
$-19.9M
$-24.5M
Q1
$-9.1M
$2.5M
Q2
$-5.8M
$-7.7M
Q3
$-34.8M
$-29.7M
Cumulative
Estimate (Forecast)Actual (Actual)
FY2025 Q3 YoY
- $-

Surprise History

ActualEstimate
FY2024MISS
$6.2M

Future Forecast